You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PROSTIN F2 ALPHA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Prostin F2 Alpha patents expire, and when can generic versions of Prostin F2 Alpha launch?

Prostin F2 Alpha is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in PROSTIN F2 ALPHA is dinoprost tromethamine. There are six drug master file entries for this compound. Additional details are available on the dinoprost tromethamine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROSTIN F2 ALPHA?
  • What are the global sales for PROSTIN F2 ALPHA?
  • What is Average Wholesale Price for PROSTIN F2 ALPHA?
Summary for PROSTIN F2 ALPHA
Drug patent expirations by year for PROSTIN F2 ALPHA
Recent Clinical Trials for PROSTIN F2 ALPHA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Medical Centre MariborPhase 4
Aswan University HospitalN/A
Yong Loo Lin School of MedicineN/A

See all PROSTIN F2 ALPHA clinical trials

US Patents and Regulatory Information for PROSTIN F2 ALPHA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROSTIN F2 ALPHA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PROSTIN F2 ALPHA

See the table below for patents covering PROSTIN F2 ALPHA around the world.

Country Patent Number Title Estimated Expiration
African Intellectual Property Organization (OAPI) 3734 ⤷  Sign Up
Sweden 387340 FORFARANDE FOR FRAMSTELLNING AV FRIFLYTANDE KRISTALLER AV TRIS-(HYDROZIMETYL)-AMINOMETANSALTET AV PGE?712 ⤷  Sign Up
Israel 36860 TRIS (HYDROXYMETHYL) AMINOMETHANE SALTS OF PGE2 AND PGF2ALPHA ⤷  Sign Up
South Africa 7103181 ⤷  Sign Up
Sweden 339531 ⤷  Sign Up
Netherlands 7107062 ⤷  Sign Up
Philippines 9620 MID-TERM ABORTION WITH PROSTAGLANDINS ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.